Targeting programmed cell death via active ingredients from natural plants: a promising approach to cancer therapy

Qian Li1,2, Yan Tong1,2, Jianxiang Chen1,2

  • 1School of Pharmacy and Department of Hepatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.

Frontiers in Pharmacology
|November 25, 2024
PubMed

Insights

Natural plant compounds show promise for cancer treatment by inducing various forms of programmed cell death (PCD) in cancer cells. This review explores their mechanisms to support the development of new anticancer drugs.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Cancer remains a significant global health challenge requiring novel therapeutic strategies.
  • Targeting programmed cell death (PCD) pathways, including apoptosis, is a key approach in cancer therapy.
  • Natural compounds from plants are increasingly recognized for their potential anticancer properties.

Purpose of the Study:

  • To review the latest research on natural plant active ingredients targeting diverse PCD pathways in cancer.
  • To elucidate the mechanisms by which these compounds induce cancer cell death.
  • To provide a theoretical foundation for developing plant-derived anticancer drugs.

Main Methods:

  • Literature review of recent studies on natural products and programmed cell death.
  • Analysis of mechanisms of action for plant-derived compounds.
  • Focus on apoptosis, autophagy, necroptosis, ferroptosis, and pyroptosis.

Main Results:

  • Natural plant compounds effectively induce various forms of programmed cell death in cancer cells.
  • Specific plant-derived molecules demonstrate targeted action against cancer cells.
  • Evidence supports the role of these compounds in disrupting cancer cell survival mechanisms.

Conclusions:

  • Natural plant active ingredients offer a promising avenue for novel cancer therapeutics.
  • Understanding their mechanisms in different PCD pathways is crucial for drug development.
  • Further research can translate these findings into clinical applications for cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K